2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2025-11-4-0-23937Genetics<strong>Frequency, spectrum, and functional significance of mutations in the <em>MIR-142</em> gene in diffuse large B-cell cell lymphoma</strong><br /> &nbsp;<strong>Frequency, spectrum, and functional significance of mutations in the <em>MIR-142</em> gene in diffuse large B-cell cell lymphoma</strong><br /> &nbsp;VoropaevaElena N.VoropaevaElena N.vena.81@mail.ruSereginaOlga B.SereginaOlga B.alepu@yandex.ruVoytkoMaria S.VoytkoMaria S.voytko.marie@yandex.ruBabaevaTatiana N.BabaevaTatiana N.babaeva_tatyana@inbox.ruSkvortsovaNatalia V.SkvortsovaNatalia V.nata_sk78@mail.ruMaksimovVladimir N.MaksimovVladimir N.medik11@mail.ruPospelovaTatiana I.PospelovaTatiana I.postatgem@mail.ru202511400

Background: MIR-142 is the only human microRNA gene that is highly mutated in diffuse large B-cell lymphoma (DLBCL). Early studies of abnormalities in this gene were based on the analysis of several lymphoma biospecimens and did not focus on assessing the functional effect of the detected changes. The aim of the study: To describe the frequency and spectrum of mutations in the MIR-142 gene in a large sample of tumor tissue samples from patients with DLBCL, as well as to analyze their functional significance in silico. Materials and methods: Direct Sanger sequencing of the MIR-142 gene was performed in 123 DNA samples isolated from sections of FFPE blocks from biopsies of tumor lymph nodes in patients with DLBCL. In silico prediction of target genes for each of the &quot;seed&quot; microRNA sequences was performed using the miRDB online tool. To determine the function of microRNA target genes, an analysis of the enrichment of terms of gene ontologies of molecular functions and biological processes using PANTHER based on the bioinformatics resource Gene Ontology was carried out. To predict the secondary structure of the microRNA hairpin and calculate its minimum free energy (dG), we used UNAfold web server. Results: The mutation rate in the study group was 16.7%, and in three cases there were multiple single-nucleotide substitutions in the MIR-142 sequence. A total of 24 types of single nucleotide substitutions were identified, with transitions prevailing over transversions. An analysis of the distribution of mutations in the sequence of the MIR-142 gene showed that only 15% were localized in &quot;key&quot; regions, while the majority were located outside it: in the sequence of mature strands (30%), the precursor (40%) or the primary transcript (10%) of microRNAs. An in silico analysis of the effect of substitutions located in the &quot;seed&quot; sequence on microRNA-mRNA interactions showed that all three mutations identified in the study group lead to a significant change in the set of regulated genes. The most pronounced changes in the spectrum of regulated genes were found for n.68G/A. Almost all of the mutations we described affected the structure and thermal stability of the hairpin microRNAs to one degree or another. Conclusion: The data obtained indicate a significant effect of mutations in the &quot;seed&quot; sequence on the switching of target genes in the mature strands of the microRNA under study. Further functional studies needed to confirm the effect of the predicted changes in thermodynamic stability and secondary structure on the biogenesis of mature microRNA strands

Background: MIR-142 is the only human microRNA gene that is highly mutated in diffuse large B-cell lymphoma (DLBCL). Early studies of abnormalities in this gene were based on the analysis of several lymphoma biospecimens and did not focus on assessing the functional effect of the detected changes. The aim of the study: To describe the frequency and spectrum of mutations in the MIR-142 gene in a large sample of tumor tissue samples from patients with DLBCL, as well as to analyze their functional significance in silico. Materials and methods: Direct Sanger sequencing of the MIR-142 gene was performed in 123 DNA samples isolated from sections of FFPE blocks from biopsies of tumor lymph nodes in patients with DLBCL. In silico prediction of target genes for each of the &quot;seed&quot; microRNA sequences was performed using the miRDB online tool. To determine the function of microRNA target genes, an analysis of the enrichment of terms of gene ontologies of molecular functions and biological processes using PANTHER based on the bioinformatics resource Gene Ontology was carried out. To predict the secondary structure of the microRNA hairpin and calculate its minimum free energy (dG), we used UNAfold web server. Results: The mutation rate in the study group was 16.7%, and in three cases there were multiple single-nucleotide substitutions in the MIR-142 sequence. A total of 24 types of single nucleotide substitutions were identified, with transitions prevailing over transversions. An analysis of the distribution of mutations in the sequence of the MIR-142 gene showed that only 15% were localized in &quot;key&quot; regions, while the majority were located outside it: in the sequence of mature strands (30%), the precursor (40%) or the primary transcript (10%) of microRNAs. An in silico analysis of the effect of substitutions located in the &quot;seed&quot; sequence on microRNA-mRNA interactions showed that all three mutations identified in the study group lead to a significant change in the set of regulated genes. The most pronounced changes in the spectrum of regulated genes were found for n.68G/A. Almost all of the mutations we described affected the structure and thermal stability of the hairpin microRNAs to one degree or another. Conclusion: The data obtained indicate a significant effect of mutations in the &quot;seed&quot; sequence on the switching of target genes in the mature strands of the microRNA under study. Further functional studies needed to confirm the effect of the predicted changes in thermodynamic stability and secondary structure on the biogenesis of mature microRNA strands

diffuse large B-cell lymphomamicroRNA regulationgene expressionmiR-142mutation profilehigh-throughput sequencingdiffuse large B-cell lymphomamicroRNA regulationgene expressionmiR-142mutation profilehigh-throughput sequencingСписок литературыPoddubnaya IV, Babicheva LG, Bariakh EA. Diffuse large B-cell lymphoma: strokes to the epidemiological portrait. A review. Journal of Modern Oncology. 2023;25(3):342-345. Russian. DOI: https://doi.org/10.26442/18151434.2024.2.202798Heath AP, Ferretti V, Agrawal S, et al. The NCI Genomic Data Commons. Nature Genetics. 2021;53(3):257-262. DOI: https://doi.org/10.1038/s41588-021-00791-5Ye X, Wang L, Nie M, et al. A single-cell atlas of diffuse large B cell lymphoma. Cell Reports. 2022;39(3):110713. DOI: https://doi.org/10.1016/j.celrep.2022.110713Lacy SE, Barrans SL, Beer PA, et al. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood. 2020;135(20):1759-1771. DOI: https://doi.org/10.1182/blood.2019003535Chapuy B, Stewart C, Dunford AJ, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nature Medicine. 2018;24(5):679-690. DOI: https://doi.org/10.1038/s41591-018-0016-8Wright GW, Huang DW, Phelan JD, et al. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications. Cancer Cell. 2020;37(4):551-568.e14. DOI: https://doi.org/10.1016/j.ccell.2020.03.015Schmitz R, Wright GW, Huang DW, et al. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. New England journal of medicine. 2018;378(15):1396-1407. DOI: https://doi.org/10.1056/NEJMoa1801445Voropaeva EN, Pospelova TI, Voevoda MI. Association of DNA repair gene xrcc1 polymorphism ARG399GLN with high-grade nonhodgkin&#39;s lymphoma risk. Russian journal of hematology and transfusiology. 2013;58(1):10-14. Russian.Voropaeva EN, Pospelova TI, Voevoda MI. The TP53 gene in diffuse B-large cell lymphoma. Novosibirsk: Nauka; 2018. Russian.Berezina OV, Weiner AS, Voropaeva EN, et al. Influence of single-nucleotide replacements in genes of folate cycle on risk of aggressive Non-hodgkin&rsquo;s lymphoma development. Siberian Medical Review. 2011;69(3):22-26. Russian.Yan J, Yuan W, Zhang J, et al. Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma. Frontiers in Endocrinology. 2022;13:846357. DOI: https://doi.org/10.3389/fendo.2022.846357Pan M, Yang P, Wang F, et al. Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell Lymphoma. Frontiers in Genetics. 2021;12:648800. DOI: https://doi.org/10.3389/fgene.2021.648800Orgueira AM, Ar&iacute;as J&Aacute;D, L&oacute;pez MC, et al. Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model. HemaSphere. 2022;6(4):e706. DOI: https://doi.org/10.1097/HS9.0000000000000706Merdan S, Subramanian K, Ayer T, et al. Gene expression profiling-based risk prediction and profiles of immune infiltration in diffuse large B-cell lymphoma. Blood Cancer Journal. 2021;11(1):2. DOI: https://doi.org/10.1038/s41408-020-00404-0Steen CB, Luca BA, Esfahani MS, et al. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell. 2021;39(10):1422-1437.e10. DOI: https://doi.org/10.1016/j.ccell.2021.08.011Machowska M, Galka-Marciniak P, Kozlowski P. Consequences of genetic variants in miRNA genes. Computational and Structural Biotechnology Journal. 2022;20:6443-6457. DOI: https://doi.org/10.1016/j.csbj.2022.11.036Voropaeva EN, Pospelova TI, Orlov YL, et al. The Methylation of the p53 Targets the Genes&nbsp;MIR-203,&nbsp;MIR-129-2,&nbsp;MIR-34A&nbsp;and&nbsp;MIR-34B/C&nbsp;in the Tumor Tissue of Diffuse Large B-Cell Lymphoma. Genes. 2022;13(8):1401. DOI: https://doi.org/10.3390/genes13081401Urbanek-Trzeciak MO, Galka-Marciniak P, Nawrocka PM, et al. Pan-cancer analysis of somatic mutations in miRNA genes. EBioMedicine. 2020;61:103051. DOI: https://doi.org/10.1016/j.ebiom.2020.103051Voropaeva EN, Orlov YL, Loginova AB, et al. Deregulation mechanisms and therapeutic opportunities of p53-responsive microRNAs in diffuse large B-cell lymphoma. PeerJ. 2025;13:e18661. DOI: https://doi.org/10.7717/peerj.18661Pawlina-Tyszko K, Semik-Gurgul E, Gurgul A, et al. Application of the targeted sequencing approach reveals the single nucleotide polymorphism (SNP) repertoire in microRNA genes in the pig genome. Scientific Reports. 2021;11(1):9848. DOI: https://doi.org/10.1038/s41598-021-89363-5Galka-Marciniak P, Kanduła Z, Tire A, et al. Mutations in the miR-142 Gene Are Not Common in Myeloproliferative Neoplasms. Scientific Reports. 2022;12:10924. DOI: https://doi.org/10.1038/s41598-022-15162-1Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Research. 2020;48(D1):D127-D131. DOI: https://doi.org/10.1093/nar/gkz757Euler-Venn diagrams [Internet] [cited 2025 March 20]. Russian. Available from: https://www.semestr.online/graph/venn.php#vennhandThomas PD, Ebert D, Muruganujan A, et al. PANTHER: Making genome-scale phylogenetics accessible to all. Protein Science. 2022;31(1):8-22. DOI: https://doi.org/10.1002/pro.4218Aleksander SA, Balhoff J, Carbon S, et al. The Gene Ontology knowledgebase in 2023. Genetics. 2023;224(1):iyad031. DOI: https://doi.org/10.1093/genetics/iyad031The UNAFold Web Server [Internet] [cited 2025 March 20]. Available from: https://www.unafold.org/Hezaveh K, Kloetgen A, Bernhart SH, et al. Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis. Haematologica. 2016;101(11):1380-1389. DOI: https://doi.org/10.3324/haematol.2016.143891Bouska A, Zhang W, Gong Q, et al. Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia. 2017;31(1):83-91. DOI: https://doi.org/10.1038/leu.2016.175Rheinbay E, Nielsen MM, Abascal F, et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature. 2020;578(7793):102-111. DOI: https://doi.org/10.1038/s41586-020-1965-xPuente XS, Be&agrave; S, Vald&eacute;s-Mas R, et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature. 2015;526(7574):519-24. DOI: https://doi.org/10.1038/nature14666Ley TJ, Miller C, Ding L, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. New England Journal of Medicine. 2013;368(22):2059-2074. DOI: https://doi.org/10.1056/NEJMoa1301689Thol F, Scherr M, Kirchner A, et al. Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia. Haematologica. 2015;100(4):e122-e124. DOI: https://doi.org/10.3324/haematol.2014.120345Menegatti J, Nakel J, Stepanov YK, et al. Changes of Protein Expression after CRISPR/Cas9 Knockout of miRNA-142 in Cell Lines Derived from Diffuse Large B-Cell Lymphoma. Cancers. 2022;14(20):5031. DOI: https://doi.org/10.3390/cancers14205031Morin RD, Assouline S, Alcaide M, et al. Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. Clinical Cancer Research. 2016;22(9):2290-2300. DOI: https://doi.org/10.1158/1078-0432.CCR-15-2123Kwanhian W, Lenze D, Alles J, et al. MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Medicine. 2012;1(2):141-155. DOI: https://doi.org/10.1002/cam4.29Hornsh&oslash;j H, Nielsen MM, Sinnott-Armstrong NA, et al. Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival. npj Genomic Medicine. 2018;3:1. DOI: https://doi.org/10.1038/s41525-017-0040-5Radke J, Ishaque N, Koll R, et al. The genomic and transcriptional landscape of primary central nervous system lymphoma. Nature Communications. 2022;13(1):2558. DOI: https://doi.org/10.1038/s41467-022-30050-yVeerla S, Staaf J. Kataegis in clinical and molecular subgroups of primary breast cancer. npj Breast Cancer. 2024;10(1):32. DOI: https://doi.org/10.1038/s41523-024-00640-8Huang W, Paul D, Calin GA, et al. miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities. Cells. 2023;13(1):84. DOI: https://doi.org/10.3390/cells13010084Liang J, Oyang L, Rao S, et al. Potential Target for Tumor Therapy. Frontiers in Oncology. 2021;11:674426. DOI: https://doi.org/10.3389/fonc.2021.674426Marshall A, Kasturiarachchi J, Datta P, et al. Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes. Scientific Reports. 2020;10(1):19390. DOI: https://doi.org/10.1038/s41598-020-76218-8Soltis AR, Bateman NW, Liu J, et al. Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways. Cell Reports Medicine. 2022;3(11):100819. DOI: https://doi.org/10.1016/j.xcrm.2022.100819Sato K, Akamatsu H, Koh Y, et al. Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes. BMC Cancer. 2022;22(1):1148. DOI: https://doi.org/10.1186/s12885-022-10246-7Lyons DM, Lauring AS. Evidence for the Selective Basis of Transition-to-Transversion Substitution Bias in Two RNA Viruses. Molecular Biology and Evolution. 2017;34(12):3205-3215. DOI: https://doi.org/10.1093/molbev/msx251Mildner A, Chapnik E, Varol D, et al. MicroRNA-142 controls thymocyte proliferation. European Journal of Immunology. 2017;47(7):1142-1152. DOI: https://doi.org/10.1002/eji.201746987Qu&eacute;m&eacute;ner AM, Bachelot L, Aubry M, et al. Non-canonical miRNA-RNA base-pairing impedes tumor suppressor activity of miR-16. Life Science Alliance. 2022;5(12):e202201643. DOI: https://doi.org/10.26508/lsa.202201643Busseau I, Mockly S, Houbron &Eacute;, et al. Evaluation of microRNA variant maturation prior to genome edition. Biochimie. 2024;217:86-94. DOI: https://doi.org/10.1016/j.biochi.2023.06.007Jouravleva K, Vega-Badillo J, Zamore PD. Principles and pitfalls of high-throughput analysis of microRNA-binding thermodynamics and kinetics by RNA Bind-n-Seq. Cell Reports Methods. 2022;2(3):100185. DOI: https://doi.org/10.1016/j.crmeth.2022.100185Gong J, Tong Y, Zhang HM, et al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Human Mutation. 2012;33(1):254-263. DOI: https://doi.org/10.1002/humu.21641Sheng P, Flood KA, Xie M. Short Hairpin RNAs for Strand-Specific Small Interfering RNA Production. Frontiers in Bioengineering and Biotechnology. 2020;8:940. DOI: https://doi.org/10.3389/fbioe.2020.00940